Every report comes from a Lived member, sent anonymously.
No reports yet
Add what worked for you with the search bar below
A heart transplant is surgery that removes a failing heart and replaces it with a healthy heart from a donor who has died. It is reserved for people whose heart can no longer pump enough blood to keep them alive or reasonably well, and for whom medicines, implanted devices and other operations have stopped working or are unlikely to help. Most recipients have end-stage heart failure caused by cardiomyopathy (disease of the heart muscle itself), damage from heart attacks, heart valve disease or a congenital heart defect that cannot be repaired. Less often, the reason is a life-threatening heart rhythm problem that no other treatment controls. Children can receive transplants, and adults are generally considered up to about age 70, with some programs accepting people up to 75. Because donor hearts are scarce, transplant programs accept people only when the operation offers a good chance of survival and a better quality of life. Serious disease in other organs, active infection, recent cancer, ongoing smoking or substance use, or not having the support to manage lifelong medicines and frequent appointments can rule someone out. A transplant is usually considered alongside other advanced heart failure options, such as a ventricular assist device (VAD), a mechanical pump implanted to help the heart circulate blood, which is often used to support people while they wait.
The process starts with a referral to a transplant center and an evaluation that usually takes several visits over weeks or months. The team checks heart function with tests such as an ECG (a recording of the heart's electrical activity), an echocardiogram (an ultrasound of the heart) and cardiac catheterization, which measures pressures inside the heart and lungs. Blood tests look at kidney and liver function, infections and blood and tissue type, and screening tests look for cancer. Social workers, financial counselors and other specialists also assess whether the person has caregivers, transportation and a realistic plan for the cost of lifelong medicines. Vaccinations need to be brought up to date beforehand, because the immune system will be deliberately suppressed afterward. If the team agrees a transplant is appropriate, the person joins a waiting list. In the United States, priority depends mainly on how urgently a heart is needed, using six statuses from 1 (the sickest) to 6 (the most stable), along with blood type and body size; for adults, the length of time on the list matters much less. Some people receive a heart within days, and others wait months or years. Many people waiting are sick enough to be in the hospital, and some need a VAD, ECMO (a machine that pumps and oxygenates blood outside the body) or intravenous heart medicines to bridge them to transplant. Those waiting at home must stay reachable and able to reach the hospital quickly when a heart becomes available.
When a donor heart is matched, the person is called to the hospital and prepared quickly. The operation is done under general anesthesia, so the person is fully asleep, with a breathing machine (ventilator) in place. The surgeon opens the chest through a long incision down the breastbone and connects the person to a heart-lung bypass machine, which takes over circulating and oxygenating blood while the heart is stopped. The diseased heart is then removed and the donor heart is sewn to the main blood vessels. Once blood flows through it, the new heart takes over, sometimes with temporary pacing wires to help it keep a steady rhythm at first, and the bypass machine is disconnected. Tubes are left in the chest for several days to drain fluid and air. The operation usually takes about 4 to 10 hours, longer when previous heart surgery or an implanted device has to be dealt with.
Recovery begins with a day or two in intensive care, followed by a hospital stay that is often around one to three weeks. Walking and breathing exercises start early, and most people join a cardiac rehabilitation program, a supervised exercise and education program, after discharge. The breastbone and incision take about six to eight weeks to heal, and full recovery takes several months. Many centers ask people to stay near the hospital for roughly the first three months, because follow-up visits, blood tests and echocardiograms are frequent. The immune system treats the new heart as foreign, so anti-rejection (immunosuppressive) medicines must be taken every day for the rest of the person's life, at the exact times and doses prescribed, with regular blood tests to adjust them. Missing doses can trigger rejection. Rejection often causes no symptoms at first, which is why heart muscle biopsies, small tissue samples taken through a thin tube passed into the heart from a vein in the neck or groin, are done frequently, often monthly, during the first 6 to 12 months and less often after that. Some centers also use specialized blood tests to reduce how many biopsies are needed. Most recipients return to their usual level of activity, often around three months after surgery once the team agrees. Returning to work is less common than many people expect, for medical, financial and practical reasons. Feeling grateful, anxious, low or overwhelmed after a transplant is common, and transplant support groups and counseling can help. While recovering at home, fever, new drainage, redness or warmth around the incision, a breastbone that feels like it is moving or clicking, a new fast heartbeat, dizziness, shortness of breath or a general feeling of being newly unwell should be reported to the transplant team right away, because infection and rejection can progress quickly with a suppressed immune system. Severe shortness of breath or dizziness is an emergency that calls for 911.
A heart transplant is major surgery performed on people who are often very ill, so the early risks are significant. They include bleeding, blood clots, stroke, kidney injury, heart rhythm problems, delirium and failure of the donor heart to work well, called graft failure. Most deaths from graft failure happen within the first 30 days. The other risks come largely from the trade-off at the heart of transplantation: the immune system has to be suppressed enough to protect the new heart, but not so much that the body cannot defend itself. Rejection can occur at any time, though it is most common in the first year. Infections are also most dangerous in the first year, including ones that rarely trouble people with normal immunity. Over the long term, anti-rejection medicines can damage the kidneys and raise the risk of high blood pressure, high cholesterol, diabetes, bone thinning and cancer, so regular cancer screening becomes part of long-term care. A distinctive long-term problem is cardiac allograft vasculopathy, a gradual narrowing of the new heart's arteries driven by the immune system. Because nerves to the transplanted heart are cut, it may not cause typical chest pain, so it is watched for with periodic imaging or catheterization. Depression and anxiety are also recognized complications. Outcomes have improved steadily. In North America, about 9 in 10 recipients are alive one year after surgery, and the median survival is around 14 years, meaning half of recipients are still alive at that point; some live more than 20 years. Individual outlook depends on age, overall health before surgery and complications afterward. A second transplant is sometimes possible but is more complex.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience with Heart transplant, what to expect, or ask the community a question.